學門類別
政大
哈佛
最新個案
- Leadership Imperatives in an AI World
- Vodafone Idea Merger - Unpacking IS Integration Strategies
- Snapchat’s Dilemma: Growth or Financial Sustainability
- V21 Landmarks Pvt. Ltd: Scaling Newer Heights in Real Estate Entrepreneurship
- Predicting the Future Impacts of AI: McLuhan’s Tetrad Framework
- Did I Just Cross the Line and Harass a Colleague?
- TNT Assignment: Financial Ratio Code Cracker
- Porsche Drive (A): Vehicle Subscription Strategy
- Porsche Drive (A) and (B): Student Spreadsheet
- Porsche Drive (B): Vehicle Subscription Strategy
-
PharmaCo - Presentation
Presentation for product 8B20M053. -
PharmaCo
PharmaCo was a large, multinational, integrated pharmaceutical company. Its board of directors was meeting to discuss a possible friendly merger with a complementary competitor and to review a quarterly cybersecurity report. However, before either of these discussions could begin, PharmaCo’s chief financial officer interrupted with news that the company’s customer database had been encrypted by hackers in a ransomware attack and a ransom of $25,000 in Bitcoin had been demanded. Unfortunately, this was the first in a series of cyber attacks affecting the organization. The board of directors must increasingly deal with a number of issues brought by management and make some critical decisions in overseeing this crisis. -
PharmaCo: Inject 1—Ransomware
Additional Supplement to accompany 9B20M053. -
PharmaCo: Inject 2—Email Theft
Additional Supplement to accompany 9B20M053. -
PharmaCo: Inject 3—Phi Theft
Additional Supplement to accompany product 9B20M053. -
PharmaCo: Inject 4—Large Breach and Phi Theft
Additional Supplement to accompany 9B20M057. -
PharmaCo: Inject 5—Malware Infection
Additional Supplement to accompany 9B20M058.